Boston Scientific reported $279M in Interest Expense on Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Expense On Debt Change
Abbott ABT:US $ 131M 0M
Atricure ATRC:US $ 1M 0.08M
Avanos Medical Inc AVNS:US $ 1.3M 600K
Baxter International BAX:US $ 88M 40M
Becton, Dickinson and BDX:US $ 101M 3M
Boston Scientific BSX:US $ 279M 192M
Cardiovascular Systems CSII:US $ 0.41M 0M
Conmed CNMD:US $ 5M 2.57M
Cooper Companies COO:US $ 10.8M 4.2M
Danaher DHR:US $ 54M 2M
Dexcom DXCM:US $ 4.6M 20.6M
Hologic HOLX:US $ 22.6M 3.1M
Illumina ILMN:US $ 6M 7M
Insulet PODD:US $ 9M 6.1M
Integra Lifesciences IART:US $ 11.66M 470K
Johnson & Johnson JNJ:US $ 10M 50M
Masimo MASI:US $ 0.1M 0.01M
Medtronic MDT:US $ 143M 6M
Merit Medical Systems MMSI:US $ 1M 103K
Nuvasive NUVA:US $ 4.38M 0.06M
Tandem Diabetes Care TNDM:US $ 1.52M 0M
Teleflex TFX:US $ 10.42M 1.59M
Zimmer Biomet Holdings Inc ZBH:US $ 41.1M 7.7M